Table 2.
Comparison of clinical features and laboratory parameters in Kawasaki disease children with and without coronary artery abnormality
| With CAA (n=12) | Without CAA (n=20) | P | |
|---|---|---|---|
| Clinical features, n (%) | |||
| Age <12 months | 8/12 (75) | 5/20 (25) | 0.006 |
| Gender | |||
| Male | 7/12 (58.3) | 14/20 (70) | 0.403 |
| Female | 5/12 (41.6) | 6/20 (30) | |
| Eye signs present | 10/12 (83.3) | 13/20 (65) | 0.178 |
| Mucosal changes present | 12/12 (100) | 17/20 (85) | 0.629 |
| Lymphadenopathy present | 5/12 (41.7) | 7/20 (35) | 0.720 |
| Extremity signs present | 5/12 (41.7) | 14/20 (70) | 0.281 |
| Rash present | 11/12 (91.7) | 17/20 (85) | 0.629 |
| Mean days of fever | 11.16±4.59 | 9.65±4.71 | 0.343 |
| Laboratory values, mean±SD | |||
| CRP (mg/L) | 56.18±47.72 | 67.28±78.09 | 0.621 |
| ESR (mm at end of 1st h) | 78.7±36.34 | 66.3±34.17 | 0.381 |
| Platelet counts (x 109/L) | 769±540 | 515±211 | 0.142 |
| TLC (×109/L) | 16.321±5.697 | 14.244±6.882 | 0.562 |
| Hemoglobin (g/L) | 93.5±13.5 | 113.8±12.4 | 0.001 |
| Liver function tests | With CAA (available in n=7/12) | Without CAA (available in n=8/20) | P |
| AST | 69.43±81.21 | 26.88±9.58 | 0.216 |
| ALT | 91±179 | 18.9±10.2 | 0.33 |
| Albumin | 3.47±0.71 | 3.85±0.35 | 0.23 |
CAA: Coronary artery abnormality, CRP: C reactive protein, ESR: Erythrocyte sedimentation rate, TLC: Total leukocyte counts, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, SD: Standard deviation